Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: February 2022

SRAX Inc. (NASDAQ: SRAX) Announces Quantity of Shares Repurchased in Q4 2021; Common Stock Dividend Paid in Preferred Shares

Posted on February 3, 2022 by MissionIR

SRAX, premier provider of investor intelligence and communications platform, announces the quantity of stock bought-back in Q4 and dividend payment $800K worth of shares was repurchased in Q4 as part of company’s $10M stock buy-back program; dividend for common stockholders … Continue reading →

Posted in SRAX, Inc. SRAX | Leave a comment

MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Blazing Trail in Defining Value of Rare Cannabinoids in Pharmaceutical Space

Posted on February 2, 2022 by MissionIR

InMed Pharmaceuticals (NASDAQ: INM) is a trailblazer, a pioneer defining the value of rare cannabinoids in the pharmaceutical sector and just how integral they are in pushing the industry forward. The global cannabis market is experiencing tremendous growth, particularly considering … Continue reading →

Posted in InMed Pharmaceuticals Inc. INM | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Laying Robust Foundation for Potentially Pivotal Global Trial

Posted on February 2, 2022 by MissionIR

CNS Pharmaceuticals (NASDAQ: CNSP) recently received approval from swissethics, the umbrella organization of the cantonal Ethics Committees in Switzerland. The first from a European Ethics Committee, the approval marks a significant milestone for the company as it journeys toward its … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Significant Findings from Sildenafil Animal Study

Posted on February 2, 2022 by MissionIR

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has reported positive findings in its recent animal study. The study was designed to evaluate LEXX’s proprietary DehydraTECH(TM) processing of the phosphodiesterase inhibitor (“PDE5 inhibitor”) sildenafil for potential use in the … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

Payments Solution Innovator GreenBox POS (NASDAQ: GBOX) Set to Build on Growth Momentum from 2021, Announces UK Fintech Acquisition along with Stunning Results for New Subsidiary

Posted on February 2, 2022 by MissionIR

GreenBox POS is an advanced blockchain technology payment solutions provider focused on expanding its FinTech portfolio through strategic acquisitions in the United States and internationally The company acquired key assets during 2021 that demonstrate its commitment to expand its balance … Continue reading →

Posted in GreenBox POS. GBOX | Leave a comment

MissionIRNewsBreaks — Save Foods Inc. (NASDAQ: SVFD) to Participate in Upcoming Virtual Aegis Conference

Posted on February 2, 2022 by MissionIR

Save Foods (NASDAQ: SVFD), an agri-food tech company specializing in eco crop protection designed to reduce food waste and ensure food safety, will be presenting at next month’s Aegis Capital Corp. Virtual Conference. The three-day conference is scheduled for Feb. … Continue reading →

Posted in Save Foods Inc. SVFD | Leave a comment

MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Availability of Replays from 2022 Sequire Metals & Mining Conference

Posted on February 2, 2022 by MissionIR

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, hosted the 2022 Sequire Metals & Mining Conference, a preeminent virtual investor event. The conference took place on … Continue reading →

Posted in SRAX, Inc. SRAX | Leave a comment

MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Seeks Approval to Study Patent-Pending Cannabinoid-Based Product to Treat COVID-19

Posted on February 2, 2022 by MissionIR

Flora Growth’s (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is hoping to begin research on its patent-pending, cannabinoid-based product. The company is requesting approval from INVIMA, the Colombian FDA, noting that recent studies … Continue reading →

Posted in Flora Growth Corp. FLGC | Leave a comment

InMed Pharmaceuticals Inc.’s (NASDAQ: INM) Recent Access of Manufacturing Technologies Now Give It the Potential to Synthetically Produce Rare Cannabinoids at Large Scale, a Unique and Coveted Position in the Rapidly Developing Rare Cannabinoid Space

Posted on February 1, 2022 by MissionIR

Rare cannabinoids are cannabinoid compounds other than CBD and THC which are not yet produced in large scale but which have potentially greater benefits InMed acquired BayMedica in October 2021, bringing on board unmatched expertise in large-scale bio-production technologies applicable … Continue reading →

Posted in InMed Pharmaceuticals Inc. INM | Leave a comment

MissionIRNewsBreaks – GreenBox POS (NASDAQ: GBOX) to Present at Winter Wonderland – Best Ideas Virtual Investor Conference

Posted on February 1, 2022 by MissionIR

GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, today announced that management will present at the Winter Wonderland Virtual Conference — Best Ideas from the Buyside, which is slated to take place from Feb. 8-11, 2022. Chairman Ben … Continue reading →

Posted in GreenBox POS. GBOX | Leave a comment